An analysis of the T. Rowe Price Small - Mid Cap ETF (TMSL) reveals a weighted average implied analyst target price of $41.26, indicating a 15.58% upside from its recent trading price of $35.70. This projected growth is significantly influenced by underlying holdings such as Vera Therapeutics Inc (VERA) and FIREFLY AEROSPACE INC (FLY), which analysts forecast to have 114.02% and 93.16% upside, respectively, alongside Belden Inc (BDC) with a 19.72% upside. While these figures suggest substantial potential, the analysis also prompts investors to critically evaluate the optimism and current relevance of these analyst targets.
The T. Rowe Price Small - Mid Cap ETF (TMSL) currently trades near $35.70 per unit, with an implied analyst 12-month forward target price of $41.26, suggesting a 15.58% potential upside. This moderately positive outlook for TMSL is derived from the weighted average of its underlying holdings' analyst targets, reflecting a general optimistic tone from analysts. Significant contributors to this projected growth include Vera Therapeutics Inc (VERA) and FIREFLY AEROSPACE INC (FLY), which analysts forecast to have substantial upsides of 114.02% to $62.54/share and 93.16% to $52.00/share, respectively. Belden Inc (BDC) also contributes, with analysts expecting a 19.72% upside to $141.60/share, highlighting specific company fundamentals driving the ETF's potential. Despite the optimistic analyst targets, the article prompts investors to critically evaluate whether these projections are justified or overly optimistic, particularly given the potential for targets to be outdated. The general sentiment is moderately positive, but the market impact score of 0.3 suggests a nuanced view, indicating that while upside exists, it warrants careful scrutiny of analyst estimates and insights.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
